These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 10612998)
1. Calcitropic hormonal status in north Indian patients with end-stage renal disease. Singh AK; Avula S; Kher V; Rao DS; Mithal A Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998 [TBL] [Abstract][Full Text] [Related]
2. Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Couttenye MM; D'Haese PC; Van Hoof VO; Lemoniatou E; Goodman W; Verpooten GA; De Broe ME Nephrol Dial Transplant; 1996 Jun; 11(6):1065-72. PubMed ID: 8671970 [TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease. Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657 [TBL] [Abstract][Full Text] [Related]
4. [Serum osteocalcin in children with chronic renal insufficiency]. Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853 [TBL] [Abstract][Full Text] [Related]
5. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels. Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806 [TBL] [Abstract][Full Text] [Related]
6. Serum vitamin D, parathyroid hormone and biochemical markers of bone turnover in normal Thai subjects. Chailurkit LO; Rajatanavin R; Teerarungsikul K; Ongphiphadhanakul B; Puavilai G J Med Assoc Thai; 1996 Aug; 79(8):499-504. PubMed ID: 8855632 [TBL] [Abstract][Full Text] [Related]
7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608 [TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
9. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Nasri H; Baradaran A; Naderi AS Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479 [TBL] [Abstract][Full Text] [Related]
10. Influence of sex and age on biochemical bone metabolism parameters. Resch H; Pietschmann P; Kudlacek S; Woloszczuk W; Krexner E; Bernecker P; Willvonseder R Miner Electrolyte Metab; 1994; 20(3):117-21. PubMed ID: 7815999 [TBL] [Abstract][Full Text] [Related]
11. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265 [TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of osteocalcin in chronic hemodialysis patients]. Nishio S; Hayashi S; Yoshihara H; Kobayagawa H Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881 [TBL] [Abstract][Full Text] [Related]
13. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure]. Broulík P; Hrubý M Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of whole PTH assay and 1-84/non-(1-84) PTH ratio in patients on hemodialysis or undergoing parathyroidectomy. Kato Y; Yamaguchi S; Yachiku S; Fujisawa M; Kawakami N Hinyokika Kiyo; 2004 Nov; 50(11):755-62. PubMed ID: 15628534 [TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers]. Tsuchida T; Ishimura E; Hirowatari K; Matsumoto N; Jono S; Miki T; Inaba M; Nishizawa Y Clin Calcium; 2005 Sep; 15 Suppl 1():156-60; discussion 160. PubMed ID: 16272650 [TBL] [Abstract][Full Text] [Related]
16. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population. Andress DL; Maloney NA; Endres DB; Sherrard DJ J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554 [TBL] [Abstract][Full Text] [Related]
17. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients. Ferreira A; Ureña P; Ang KS; Simon P; Morieux C; Souberbielle JC; de Vernejoul MC; Drüeke TB Nephrol Dial Transplant; 1995; 10(9):1701-7. PubMed ID: 8559492 [TBL] [Abstract][Full Text] [Related]
18. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? Coen G; Manni M; Mantella D; Pierantozzi A; Balducci A; Condò S; DiGiulio S; Yancovic L; Lippi B; Manca S; Morosetti M; Pellegrino L; Simonetti G; Gallucci MT; Splendiani G Nephrol Dial Transplant; 2007 Nov; 22(11):3262-7. PubMed ID: 17597083 [TBL] [Abstract][Full Text] [Related]
19. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Inaba M; Nagasue K; Okuno S; Ueda M; Kumeda Y; Imanishi Y; Shoji T; Ishimura E; Ohta T; Nakatani T; Kim M; Nishizawa Y Am J Kidney Dis; 2002 Jun; 39(6):1261-9. PubMed ID: 12046040 [TBL] [Abstract][Full Text] [Related]
20. [The effect of decreasing serum calcium in serum during hemodialysis on PTH levels in children with end stage renal disease]. Sieniawska M; Ziółkowska H; Pańczyk-Tomaszewska M; Weglarska J Pediatr Pol; 1995 Dec; 70(12):1017-22. PubMed ID: 8649940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]